RHHBY - Roche Holding AG

Other OTC - Other OTC Delayed Price. Currency in USD

Roche Holding AG

Konzern Hauptsitz
Grenzacherstrasse 124
Basel 4070
41 61 688 11 11

IndustryDrug Manufacturers—General
Full Time Employees94,442

Key Executives

NameTitlePayExercisedYear Born
Dr. Severin SchwanCEO & Exec. DirectorN/AN/A1967
Dr. Alan HippeChief Financial & IT OfficerN/AN/A1967
Dr. Karl MahlerHead of Investor RelationsN/AN/AN/A
Dr. Urs JaisliChief Compliance OfficerN/AN/A1956
Ms. Claudia BöckstiegelGen. CounselN/AN/A1964
Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Roche Holding AG engages in the prescription pharmaceuticals and diagnostics businesses in Switzerland, Germany, and internationally. It offers pharmaceutical products for treating anaemia, cancer, cardiovascular, central nervous system, dermatology, hepatitis B and C, HIV/AIDS, inflammatory and autoimmune, intensive care medicine, leukemia, lymphoma, metabolic disorders, obesity, ophthalmology, osteoporosis, respiratory disorders, rheumatoid arthritis, skin cancer, and transplantation. The company also offers in vitro diagnostics solutions for indications, such as cardiology, hematology, blood donor screening, coagulation, infectious disease, gynecology, and women's health, as well oncology. In addition, it provides supplies a array of instruments and reagents, and test kits for use in the diverse research market. The company was founded in 1896 and is headquartered in Basel, Switzerland.

Corporate Governance

Roche Holding AG’s ISS Governance QualityScore as of December 6, 2019 is 5. The pillar scores are Audit: 1; Board: 4; Shareholder Rights: 1; Compensation: 8.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.